Literature DB >> 10337423

Classification of ocular atopic/allergic disorders and conditions: an unsolved problem.

M Calonge1.   

Abstract

PURPOSE: To review the different classifications of ocular allergic diseases and to define the most suitable one according to the current understanding of the pathophysiology and clinical course of these disorders.
METHODS: Review of the major published ocular allergy classifications.
RESULTS: Based on past and present classifications, the author proposes the following classification: 1. allergic conjunctivitis (acute and chronic); 2. giant papillary conjunctivitis; 3. vernal keratoconjunctivitis; and 4. atopic keratoconjunctivitis. In addition, use of the term "allergic conjunctivitis" as a synonym for all ocular allergic disease is discouraged.
CONCLUSION: The proposed classification for ocular allergic disorders intends to unify the present criteria and to serve as an initial forum of discussion. This should enhance a common understanding among and between ophthalmologists and other allergy specialists. Constructive criticism of this classification system is required for further improvement.

Entities:  

Mesh:

Year:  1999        PMID: 10337423     DOI: 10.1111/j.1600-0420.1999.tb01164.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand Suppl        ISSN: 1395-3931


  8 in total

1.  Impact of screen exposure on pediatric vernal Keratoconjunctivitis: a survey during the COVID-19 pandemic in Italy.

Authors:  Marzio Masini; Giulia Brindisi; Roberto Caputo; Anna Maria Zicari; Mattia Giovannini; Elia Pignataro; Laura Di Grande; Cinzia De Libero; Marcella Nebbioso; Francesca Mori
Journal:  Ital J Pediatr       Date:  2022-05-14       Impact factor: 3.288

2.  Therapeutic effect of 0.1% Tacrolimus Eye Ointment in Allergic Ocular Diseases.

Authors:  Rakesh K Barot; Satish C Shitole; Nupur Bhagat; Deepak Patil; Pawan Sawant; Kalpita Patil
Journal:  J Clin Diagn Res       Date:  2016-06-01

3.  Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy.

Authors:  Eiichi Uchio; Ryoji Kimura; Hironori Migita; Masahiko Kozawa; Kazuaki Kadonosono
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-17       Impact factor: 3.117

Review 4.  Animal models of ocular allergy and their clinical correlations.

Authors:  Margarita Calonge; Karyn F Siemasko; Michael E Stern
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

5.  Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops.

Authors:  Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2008-09

Review 6.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Authors:  Suzanne Hagan; Eilidh Martin; Amalia Enríquez-de-Salamanca
Journal:  EPMA J       Date:  2016-07-13       Impact factor: 6.543

7.  Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.

Authors:  Atsuki Fukushima; Yuichi Ohashi; Nobuyuki Ebihara; Eiichi Uchio; Shigeki Okamoto; Naoki Kumagai; Jun Shoji; Etsuko Takamura; Yayoi Nakagawa; Kenichi Namba; Hiroshi Fujishima; Dai Miyazaki
Journal:  Br J Ophthalmol       Date:  2014-04-02       Impact factor: 4.638

8.  Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies.

Authors:  Edward Meier; Abhijit Narvekar; Ganesh R Iyer; Harvey B DuBiner; Apinya Vutikullird; David Wirta; Kenneth Sall
Journal:  Clin Ophthalmol       Date:  2017-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.